Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinoma.
Hiroki IshiharaHironori FukudaKazuhiko YoshidaYasunobu HashimotoTsunenori KondoToshio TakagiPublished in: International journal of urology : official journal of the Japanese Urological Association (2022)